Advent Technologies Announces Dr. Ryan Pavlicek as General Manger of Livermore Facility
Advent Technologies Holdings (NASDAQ: ADN) has announced the appointment of Dr. Ryan Pavlicek as General Manager of its Livermore facility. Dr. Pavlicek, who previously served with Advent from 2018-2024 in various roles, returns to the company after serving as Technology Manager at the U.S. Department of Energy's Hydrogen and Fuel Cell Technologies Office.
With over 10 years of experience in fuel cell technologies, Dr. Pavlicek played a crucial role in developing the Ion Pair electrode within the DOE L'Innovator program. He holds a PhD in Chemistry from Northeastern University and a B.S. from Carnegie Mellon University. His appointment aims to advance the commercialization of Advent's Ion Pair Technology in the Honey Badger™ product line for battery charging applications.
Advent Technologies Holdings (NASDAQ: ADN) ha annunciato la nomina del Dott. Ryan Pavlicek come Direttore Generale della sua struttura di Livermore. Il Dott. Pavlicek, che aveva già lavorato in Advent dal 2018 al 2024 in diversi ruoli, torna in azienda dopo aver ricoperto il ruolo di Technology Manager presso l'Ufficio per le Tecnologie dell'Idrogeno e delle Celle a Combustibile del Dipartimento dell'Energia degli Stati Uniti.
Con oltre 10 anni di esperienza nelle tecnologie delle celle a combustibile, il Dott. Pavlicek ha avuto un ruolo fondamentale nello sviluppo dell'elettrodo Ion Pair all'interno del programma DOE L'Innovator. È in possesso di un dottorato in Chimica conseguito alla Northeastern University e di una laurea presso la Carnegie Mellon University. La sua nomina ha l'obiettivo di promuovere la commercializzazione della tecnologia Ion Pair di Advent nella linea di prodotti Honey Badger™ per applicazioni di ricarica delle batterie.
Advent Technologies Holdings (NASDAQ: ADN) ha anunciado el nombramiento del Dr. Ryan Pavlicek como Gerente General de su instalación en Livermore. El Dr. Pavlicek, que previamente trabajó en Advent desde 2018 hasta 2024 en diversos cargos, regresa a la empresa tras desempeñarse como Gerente de Tecnología en la Oficina de Tecnologías de Hidrógeno y Celdas de Combustible del Departamento de Energía de EE.UU.
Con más de 10 años de experiencia en tecnologías de celdas de combustible, el Dr. Pavlicek desempeñó un papel clave en el desarrollo del electrodo Ion Pair dentro del programa DOE L'Innovator. Posee un doctorado en Química de la Northeastern University y una licenciatura de Carnegie Mellon University. Su nombramiento tiene como objetivo impulsar la comercialización de la tecnología Ion Pair de Advent en la línea de productos Honey Badger™ para aplicaciones de carga de baterías.
Advent Technologies Holdings (NASDAQ: ADN)는 리버모어 시설의 총괄 매니저로 Dr. Ryan Pavlicek를 임명했다고 발표했습니다. Dr. Pavlicek는 2018년부터 2024년까지 Advent에서 다양한 역할을 수행한 바 있으며, 미국 에너지부 수소 및 연료전지 기술 사무국에서 기술 매니저로 근무한 후 회사에 복귀했습니다.
연료전지 기술 분야에서 10년 이상의 경력을 가진 Dr. Pavlicek는 DOE L'Innovator 프로그램 내 Ion Pair 전극 개발에 중요한 역할을 했습니다. 그는 Northeastern University에서 화학 박사 학위를, Carnegie Mellon University에서 학사 학위를 받았습니다. 그의 임명은 배터리 충전 응용 분야를 위한 Honey Badger™ 제품군 내 Advent의 Ion Pair 기술 상용화를 촉진하는 데 목적이 있습니다.
Advent Technologies Holdings (NASDAQ: ADN) a annoncé la nomination du Dr Ryan Pavlicek en tant que Directeur Général de son site de Livermore. Le Dr Pavlicek, qui a précédemment travaillé chez Advent de 2018 à 2024 à divers postes, revient dans l'entreprise après avoir occupé le poste de Responsable Technologie au sein du Bureau des Technologies de l'Hydrogène et des Piles à Combustible du Département de l'Énergie des États-Unis.
Fort de plus de 10 ans d'expérience dans les technologies des piles à combustible, le Dr Pavlicek a joué un rôle clé dans le développement de l'électrode Ion Pair dans le cadre du programme DOE L'Innovator. Il est titulaire d'un doctorat en chimie de la Northeastern University et d'une licence de la Carnegie Mellon University. Sa nomination vise à accélérer la commercialisation de la technologie Ion Pair d'Advent dans la gamme de produits Honey Badger™ dédiée aux applications de recharge de batteries.
Advent Technologies Holdings (NASDAQ: ADN) hat die Ernennung von Dr. Ryan Pavlicek zum General Manager seiner Einrichtung in Livermore bekannt gegeben. Dr. Pavlicek, der von 2018 bis 2024 in verschiedenen Funktionen bei Advent tätig war, kehrt nach seiner Tätigkeit als Technology Manager im Büro für Wasserstoff- und Brennstoffzellentechnologien des US-Energieministeriums zum Unternehmen zurück.
Mit über 10 Jahren Erfahrung in Brennstoffzellentechnologien spielte Dr. Pavlicek eine entscheidende Rolle bei der Entwicklung der Ion Pair-Elektrode im DOE L'Innovator-Programm. Er besitzt einen Doktortitel in Chemie von der Northeastern University und einen Bachelor-Abschluss der Carnegie Mellon University. Mit seiner Ernennung soll die Kommerzialisierung der Ion Pair-Technologie von Advent in der Honey Badger™-Produktlinie für Batterie-Ladeanwendungen vorangetrieben werden.
- Dr. Pavlicek brings significant expertise in Ion Pair Technology and government programs
- Previous experience with Advent (2018-2024) ensures smooth transition and familiarity with company operations
- Strong academic and professional background with over 10 years of fuel cell technology experience
- None.
LIVERMORE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Dr. Ryan Pavlicek has rejoined the Company as the General Manager of its Livermore facility.
Dr. Pavlicek previously served as a Senior Scientist, Product Manager, and Site Lead with Advent from 2018-2024. Prior to this, Dr. Pavlicek served as a Technology Manager with the Hydrogen and Fuel Cell Technologies Office at the U.S. Department of Energy. Dr. Pavlicek has more than 10 years experience developing and scaling fuel cell technologies, and was a key member leading the team developing the Ion Pair electrode within the DOE L'Innovator program, in partnership with Los Alamos National Lab, Brookhaven National Lab, and the National Renewable Energies Lab. Dr. Pavlicek holds a PhD in Chemistry from Northeastern University as well as a B.S. in Chemistry from Carnegie Mellon University.
Emory De Castro, Advent’s Chief Technology Officer stated, “We welcome the return of Dr. Pavlicek to the Company, Ryan was the second scientist Advent hired, and is well versed in commercializing advanced membrane electrode assemblies. We look forward to his shepherding Ion Pair Technology in our Honey Badger™ product line for in-the-field battery charging mission critical applications and working with the entire team on executing on the vision of Advent 2.0.”
Gary Herman the CEO of Advent stated, “We are thrilled to have Dr. Pavlicek back on the Advent team. His experience and background in Ion Pair Technology and government programs will contribute to enhancing the Company’s goal to increase the commercialization of our innovative and cutting-edge technology."
About Advent Technologies Holdings, Inc.
Advent Technologies Holdings, Inc. is a U.S. corporation that develops, manufactures, and assembles complete fuel cell systems as well as supplying customers with critical components for fuel cells in the renewable energy sector. Advent is headquartered in Livermore, CA, with offices in Athens and Patras Greece. With approximately 150 patents issued, pending, and/or licensed for fuel cell technology, Advent holds the IP for next-generation HT-PEM that enables various fuels to function at high temperatures and under extreme conditions, suitable for the automotive, aviation, defense, oil and gas, marine, and power generation sectors. For more information, visit www.advent.energy.
Cautionary Note Regarding Forward-Looking Statements
This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company’s ability to maintain the listing of the Company’s common stock on Nasdaq; future financial performance; public securities’ potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance Advent’s corporate reputation and brand; expectations concerning its relationships and actions with technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company’s business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading “Risk Factors” in Advent’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on August 13, 2024, as well as the other information filed with the SEC. Investors are cautioned not to place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read Advent’s filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements. Advent’s business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.
Advent Technologies Holdings, Inc.
press@advent.energy
FAQ
Who is the new General Manager of Advent Technologies' (ADN) Livermore facility?
What is Dr. Ryan Pavlicek's experience in the fuel cell industry?
What will be Dr. Pavlicek's main focus at Advent Technologies (ADN)?
What is Dr. Ryan Pavlicek's educational background?
